comparemela.com
  1. Home
  2. Live Updates
  3. Arvinas Estrogen Receptor - Breaking News

Latest Breaking News On - Arvinas estrogen receptor - Page 1 : comparemela.com

Clinical Trial: Vepdegestrant vs Fulvestrant in ER+, HER2- Advanced Breast Cancer

Researchers are conducting a phase 3 trial to compare vepdegestrant to fulvestrant in patients with ER+, HER2- advanced breast cancer.

Arvinas estrogen receptor incArvinas estrogen receptor

Updated results on a new approach to treating advanced ER-positive/HER2-negative breast cancer

A UCLA Jonsson Comprehensive Cancer Center researcher and collaborators in a multicenter study will present updated results and plans for further research on a new approach to treating advanced ER-positive/HER2-negative breast cancer.

North carolinaUnited statesNorwalk hospitalStanford universityNew havenSan antonioWashington universitySan franciscoSara hurvitzRita nandaRichard gedrichRinath jeselsohnMelinda telliEmily hendersonHaolan luPamela munster

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.